The past 12 months have been an exciting time for BioMed Central. We’ve kick-started initiatives to push the publishing industry forward, listened, learned, taken action on feedback from our communities, and refreshed our identity to reflect that we have always been, and continue to be, a progressive presence in the publishing world.

We have moved from BioMed Central, the open access publisher, to simply BMC, and renewed our commitment to research in progress and innovation. We benefit from being part of Springer Nature, our parent company which advances discovery by publishing robust and insightful research, supporting the development of new areas of knowledge, making ideas and information accessible around the world, and leading the way in open access.

In 2017 we have enabled researchers to publish 70,000 open access articles, contributing to over five million article downloads.

In 2017 we have enabled researchers to publish 70,000 open access articles, contributing to over five million article downloads. Our proactive approach to promoting open access research has further increased the visibility and reach of our authors’ research.

This year we have launched trials of new peer review systems to see if there are ways to make the process more robust, and science more reproducible. Based on the discussions at the 2016 SpotOn conference, BMC and Digital Science issued a report  that examines how peer review can be improved for future generations.

Our ‘Research in Progress’ report aims to showcase what BMC represents. By celebrating our successes of the past year and informing you of our future plans, we want to show you that BMC shares the same spirit and ambition as the researchers we partner with, and that we are committed to being as forward thinking, fast paced and progressive as the communities we serve.

You can read the full report here.